Syndax Pharmaceuticals Inc (SNDX) Stock Price & News

SNDX:NASDAQ

Syndax Pharmaceuticals Inc

16,99 USD

+0,53%

(+0,090) 1D

17,75 USD

+4,47% (+0,76)

After hours

Closed: 9-окт., 16:00:00 GMT-4 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for SNDX...

Open

16,91 USD

High

17,42 USD

Low

16,78 USD

Mkt. cap

1,52 млд

Avg. vol.

1,73 млн

Volume

1,46 млн

52-wk high

25,59 USD

52-wk low

13,00 USD

EPS

-2,52 USD

Beta

0,43

Shares outstanding

89,30 млн

No. of employees

298

Open

16,91 USD

High

17,42 USD

Low

16,78 USD

Mkt. cap

1,52 млд

Avg. vol.

1,73 млн

Volume

1,46 млн

52-wk high

25,59 USD

52-wk low

13,00 USD

EPS

-2,52 USD

Beta

0,43

Shares outstanding

89,30 млн

No. of employees

298

Related stocks

NTLA

Intellia Therapeutics Inc

13,07 USD

+3,73%

ARQT

Arcutis Biotherapeutics Inc

26,58 USD

+8,53%

KLRA

Kailera Therapeutics Inc

News stories

From web sources and news partners

MarketBeat

2 күн мурун

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock Now Rated "Moderate Buy" by Sell-Side Analysts

https://www.dars.gov.et/

3 күн мурун

SNDX Q2 2026 Earnings: Wider-Than-Expected Loss Weighs on Shares - Earnings Growth Analysis

About Syndax Pharmaceuticals Inc

CEO-

Employees298

Founded2005

Headquarters-

Sector-

Websitesyndax.com

Analyst	Recommendation	Action	Price target	Projected	Date
Andres Y. Maldonado H.C. Wainwright	Buy	Reiterated	38,00 USD	+123,7%	10/01/2026
Yigal Nochomovitz Citi	Buy	Maintained	57,00 USD	+235,5%	09/29/2026
David Dai UBS	Buy	Reiterated	33,00 USD	+94,2%	08/21/2026
Stephen Willey Stifel Nicolaus	Buy	Maintained	40,00 USD	+135,4%	08/14/2026
Anupam Rama J.P. Morgan	Buy	Maintained	40,00 USD	+135,4%	08/11/2026
Jason Zemansky Bank of America Securities	Buy	Maintained	26,00 USD	+53%	08/05/2026
Etzer Darout Barclays	Buy	Maintained	37,00 USD	+117,8%	08/05/2026
Phil Nadeau TD Cowen	Buy	Maintained	-	-	08/04/2026
Bradley Canino Guggenheim	Buy	Maintained	31,00 USD	+82,5%	07/14/2026
Corinne Johnson Goldman Sachs	Buy	Maintained	34,00 USD	+100,1%	07/14/2026
Faisal Khurshid Jefferies	Buy	Maintained	37,00 USD	+117,8%	05/01/2026
Unknown Analyst Jefferies	Buy	Maintained	40,00 USD	+135,4%	03/30/2026
Unknown Analyst Mizuho Securities	Buy	Maintained	43,00 USD	+153,1%	03/30/2026
Salim Syed Mizuho Securities	Buy	Maintained	43,00 USD	+153,1%	03/30/2026

All values in USD	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	45,87 млн	68,73 млн	64,86 млн	72,79 млн
Cost of goods sold	58,38 млн	81,35 млн	61,48 млн	71,24 млн
Cost of revenue	58,38 млн	81,35 млн	61,48 млн	71,24 млн
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	44,92 млн	49,93 млн	37,59 млн	41,54 млн
Operating expense	44,92 млн	49,93 млн	37,59 млн	41,54 млн
Total operating expenses	103,30 млн	131,28 млн	99,07 млн	112,78 млн
Operating income	-57,43 млн	-62,55 млн	-34,20 млн	-40,00 млн
Other non operating income	-275,00 миң	-201,00 миң	-186,00 миң	-438,00 миң
EBT including unusual items	-60,72 млн	-68,01 млн	-42,67 млн	-49,36 млн
EBT excluding unusual items	-60,72 млн	-68,01 млн	-42,67 млн	-49,36 млн
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-60,72 млн	-68,01 млн	-42,67 млн	-49,36 млн
Net profit margin	-132,36%	-98,96%	-65,79%	-67,82%
Earnings per share	-0,70	-0,78	-0,48	-0,55
Interest and investment income	5,27 млн	4,33 млн	3,56 млн	3,75 млн
Interest expense	-8,28 млн	-9,59 млн	-11,85 млн	-12,68 млн
Net interest expenses	-3,01 млн	-5,26 млн	-8,28 млн	-8,93 млн
Depreciation and amortization charges	-	-	-	-
EBITDA	-57,42 млн	-62,54 млн	-34,20 млн	-39,99 млн
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything